Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
NCT06516965· Phase 3· Incyte Corporation· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error